Page 3 - Best Testicular cancer doctors: TOP 103 doctors

Dr. Dror Levin specializes in pediatric oncology, with a focus on bone cancer (sarcoma) in children at Sourasky Medical Center.

• Director of children's hematology oncology department at Sourasky Medical Center
• Specialized in pediatric hematology and oncology at Schneider Children's Medical Center
• Member of the Israel Society of Pediatric Hematology and Oncology (ISPHO)
• Trained in bone and soft tissue oncology at Rizzoli Orthopaedic Institute in Italy

Internationally recognized oncologist with over 22 years of experience of experience leading clinical divisions and research in targeted cancer therapies. He practices personalized medicine at Wiener Privatklinik.

• Expert in solid tumor oncology, especially breast and gynecologic cancers
• Associate Professor at the Medical University of Vienna, contributing to new treatment strategies
• Deputy Head of Clinical Division of Oncology, advancing translational cancer research
• Specializes in biomarker development and individualized systemic therapy

Dr. Avi Beri specializes in comprehensive urological treatments at Sourasky Medical Center, including prostatectomy and TURP.

• Expert in kidney stones treatment and vasectomy
• Provides urology consultations for various conditions
• Focuses on helping patients achieve a healthy life

Prof. Jack Baniel leads urology at Rabin Medical Center, specializing in nerve-sparing cancer surgeries with robotic precision. He founded the oncourology department at Beilinson Hospital.

• Performs bladder reconstruction and robotic prostatectomy
• Published 100+ scientific articles on uro-oncology
• Member of European and American urology associations
• Involved in global clinical research collaborations

Prof. Haim Matskin is a leading authority in onco-urology, specializing in testicular cancer treatment at Sourasky Medical Center.

• Heads the Urology Department at Sourasky Medical Center
• Expert in brachytherapy and cryotherapy for malignant tumors
• Member of the Medical Association of Israel and international urology associations

Associate Professor Dr. Yusuf Acikgoz brings international oncology expertise from Ohio State University to Lokman Hekim University Ankara Hospital.

• Specializes in medical oncology with a focus on testicular cancer
• Participated in Phase III clinical trials like CheckMate-649 and Fortitude-101
• Certified in Good Clinical Practice and Human Subjects Protection
• Member of American Society of Clinical Oncology (ASCO)

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Internal Medicine Specialist with experience at multiple oncology clinics in Turkey
• Promoted to Associate Professor in 2016
• Studied at Selcuk University Faculty of Medicine

Chief Physician at a certified cancer center, Phd Viola Fox specializes in innovative treatments for testicular cancer.

• 14 years of experience of experience in oncology
• Expert in chemotherapy, immunotherapy, and targeted therapy
• Qualified specialist in genetics for personalized treatment plans
• Active member of German and American cancer research societies

Professor Keil specializes in interventional radiology, using advanced imaging to guide precise treatments. Currently heads the Diagnostic and Interventional Radiology Clinic at Academic Hospital Solingen.

• Over 22 years of experience of experience in radiology and interventional procedures
• Expert in CT, MRI, and ultrasound-guided interventions for accurate diagnosis and treatment
• Former leading doctor at University Hospital of Aachen under renowned specialists
• Member of Germany's top radiology teams for complex cases

Professor Cemil Bilir brings over 21 years of experience of specialized experience in medical oncology, with training at top institutions like Cleveland Clinic and Northeastern University.

• Specializes in treating testicular cancer using the latest protocols
• Member of ASCO and ESMO – stays current with global standards
• Teaches future oncologists as a professor at Sakarya University
• Completed fellowship at Northeastern University's Center for Pharmaceutical Biotechnology

Associate Professor Nail Paksoy specializes in testicular cancer treatment, with a medical oncology fellowship from Istanbul University and ESMO Board Certification.

• Participated in 8 international clinical trials for cancer treatments
• Published multiple studies on metastatic cancers in peer-reviewed journals
• Member of the European Society for Medical Oncology (ESMO)

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

49 years of experience specializing in virotherapy – Dr. Jaunalksne leads the Clinical Immunology Center at Pauls Stradins Clinical University Hospital.

• Graduate of Riga Medical Institute with an internship in Internal Medicine
• Head of Clinical Immunology Center – oversees cutting-edge immunology treatments
• Focuses on innovative virotherapy approaches for cancer treatment

Dr. Ozden brings over 27 years of experience of experience in internal medicine and medical oncology, specializing in testicular cancer at VM Medical Park Pendik Hospital.

• Completed medical oncology subspecialty at Kocaeli University Faculty of Medicine
• Practiced at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital
• Graduated from Istanbul University, Cerrahpaşa Faculty of Medicine

Specializing in medical oncology, Dr. Alemdar brings focused expertise in testicular cancer at Medical Park Antalya Hospital Complex.

• Trained at Akdeniz University, one of Turkey's leading medical schools
• Over 20 years of experience of dedicated experience in medical oncology
• Handles both diagnosis and treatment planning for testicular cancer
• Works at a JCI-accredited hospital with advanced oncology facilities

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.